Pharmaceutical Grade 5-Aminosalicylic Acid (5-ASA) represents a high-purity active pharmaceutical ingredient essential for modern gastroenterological treatments. As the active meta...

Pharmaceutical Grade 5-Aminosalicylic Acid (5-ASA) represents a high-purity active pharmaceutical ingredient essential for modern gastroenterological treatments. As the active metabolite of Sulfasalazine, this off-white to pinkish crystalline compound delivers proven anti-inflammatory properties specifically targeting the gastrointestinal tract. Its chemical stability and well-documented pharmacokinetic profile make it a reliable foundation for medications requiring consistent therapeutic outcomes. The compound's sensitivity to moisture and insolubility in water necessitate proper handling protocols, while its acidic nature (approximately pH 4.1 in aqueous solutions) contributes to its targeted action in inflammatory environments.

The pharmaceutical manufacturing industry relies heavily on 5-Aminosalicylic Acid for producing medications that treat inflammatory bowel diseases, particularly ulcerative colitis and Crohn's disease. Research laboratories and biotechnology firms utilize this compound for developing novel therapeutic approaches and studying inflammatory pathways. Chemical synthesis operations incorporate 5-ASA as a building block for creating specialized derivatives and fine chemicals. Healthcare providers depend on medications containing this API for managing chronic gastrointestinal conditions, making it a cornerstone of gastroenterological treatment protocols worldwide.

Businesses benefit from this Pharmaceutical Grade 5-ASA through its consistent quality, regulatory compliance, and proven therapeutic efficacy. Manufacturers gain reliable supply chain stability with a compound that meets stringent pharmaceutical standards, reducing production risks and ensuring batch-to-batch consistency. The API's established safety profile and extensive clinical documentation provide confidence in product development and regulatory submissions. Its compatibility with various formulation technologies allows for flexible product development across different delivery systems. The compound's targeted mechanism of action translates to effective treatments that support patient outcomes and healthcare provider satisfaction.

Key Features:
- Pharmaceutical grade purity suitable for medication formulation and regulatory compliance.
- Proven anti-inflammatory properties as the active metabolite of Sulfasalazine.
- Off-white to pinkish crystalline form with consistent physical characteristics.
- Specific storage requirements due to moisture sensitivity and water insolubility.
- Acidic aqueous solution profile (approximately pH 4.1) supporting targeted gastrointestinal action.

Benefits:
- Reliable therapeutic outcomes for inflammatory bowel disease treatments.
- Consistent quality meeting stringent pharmaceutical manufacturing standards.
- Established safety profile with extensive clinical documentation.
- Flexible formulation compatibility across various medication delivery systems.
- Targeted action minimizing systemic side effects for improved patient tolerance.